blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2310001

EP2310001 - TRANSDERMAL ESTRADIOL DEVICE AND DELIVERY [Right-click to bookmark this link]
Former [2011/16]TRANSDERMAL ESTROGEN DEVICE AND DELIVERY
[2015/07]
StatusPatent revoked
Status updated on  15.04.2019
Database last updated on 03.12.2024
FormerThe patent has been granted
Status updated on  13.02.2017
Most recent event   Tooltip03.06.2022Lapse of the patent in a contracting state
New state(s): TR		published on 06.07.2022  [2022/27]
Applicant(s)For all designated states
Noven Pharmaceuticals, INC.
11960 Southwest 144th Street
Miami, FL 33186 / US
[2011/16]
Inventor(s)01 / MANTELLE, Juan
10821 S.W. 92 Avenue
Miami FL 33176 / US
 [2011/16]
Representative(s)Zacco Denmark A/S
Arne Jacobsens Allé 15
2300 Copenhagen S / DK
[2015/27]
Former [2013/03]Zacco Denmark A/S
Hans Bekkevolds Allé 7
2900 Hellerup / DK
Former [2011/16]Sommer, Michael Bech, et al
Zacco Denmark A/S Hans Bekkevolds Allé 7
DK-2900 Hellerup / DK
Application number, filing date09790211.809.07.2009
[2011/16]
WO2009US50069
Priority number, dateUS2008021681110.07.2008         Original published format: US 216811
[2011/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010006143
Date:14.01.2010
Language:EN
[2010/02]
Type: A2 Application without search report 
No.:EP2310001
Date:20.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 14.01.2010 takes the place of the publication of the European patent application.
[2011/16]
Type: B1 Patent specification 
No.:EP2310001
Date:01.07.2015
Language:EN
[2015/27]
Search report(s)International search report - published on:EP07.04.2011
ClassificationIPC:A61K9/70, A61K31/565
[2011/16]
CPC:
A61K9/7069 (EP,KR,US); A61K9/0021 (KR); A61K31/565 (EP,KR,US);
A61K47/10 (EP,KR,US); A61K47/32 (KR,US); A61K9/0014 (US);
A61K9/7061 (EP,KR,US); A61P15/00 (EP); A61P15/12 (EP);
A61P17/00 (EP); A61P5/30 (EP); A61K2121/00 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/27]
Former [2011/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesAL27.01.2011
BA27.01.2011
RS27.01.2011
TitleGerman:TRANSDERMALE ÖSTRADIOLVORRICHTUNG UND FREISETZUNG[2015/07]
English:TRANSDERMAL ESTRADIOL DEVICE AND DELIVERY[2015/07]
French:DISPOSITIF D'ADMINISTRATION TRANSDERMIQUE D'ESTRADIOL[2015/07]
Former [2011/16]TRANSDERMALE ÖSTROGENVORRICHTUNG UND FREISETZUNG
Former [2011/16]TRANSDERMAL ESTROGEN DEVICE AND DELIVERY
Former [2011/16]DISPOSITIF D'ADMINISTRATION TRANSDERMIQUE D' STROGÈNES
Entry into regional phase27.01.2011National basic fee paid 
27.01.2011Designation fee(s) paid 
27.01.2011Examination fee paid 
Examination procedure27.01.2011Examination requested  [2011/16]
30.05.2011Amendment by applicant (claims and/or description)
15.07.2013Despatch of a communication from the examining division (Time limit: M06)
16.01.2014Reply to a communication from the examining division
05.01.2015Cancellation of oral proceeding that was planned for 13.01.2015
13.01.2015Date of oral proceedings (cancelled)
28.01.2015Communication of intention to grant the patent
11.05.2015Fee for grant paid
11.05.2015Fee for publishing/printing paid
11.05.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15173544.6  / EP3173078
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.07.2013
Opposition(s)Opponent(s)01  23.03.2016  30.03.2016  ADMISSIBLE
3M Innovative Properties Company
3M Center
P.O. Box 33427
St. Paul MN 55133-3427 / US
Opponent's representative
Hettstedt, Stephan
3M Deutschland GmbH
3M Office for Intellectual Property Counsel
Carl-Schurz-Strasse 1
41453 Neuss / DE
 [N/P]
Former [2016/18]
Opponent(s)01  23.03.2016  30.03.2016  ADMISSIBLE
3M Innovative Properties Company
3M Center P.O. Box 33427
St. Paul MN 55133-3427 / US
Opponent's representative
Hettstedt, Stephan
3M Deutschland GmbH
Carl-Schurz-Strasse 1
41453 Neuss / DE
20.05.2016Invitation to proprietor to file observations on the notice of opposition
14.02.2017Despatch of communication that the patent will be revoked
24.02.2017Legal effect of revocation of patent [2017/26]
Fees paidRenewal fee
16.07.2011Renewal fee patent year 03
10.07.2012Renewal fee patent year 04
08.07.2013Renewal fee patent year 05
08.07.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.07.2009
BG01.07.2015
CH01.07.2015
CY01.07.2015
CZ01.07.2015
EE01.07.2015
HR01.07.2015
LI01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
MT01.07.2015
PL01.07.2015
RO01.07.2015
SI01.07.2015
SK01.07.2015
SM01.07.2015
TR01.07.2015
LU09.07.2015
NO01.10.2015
IS01.11.2015
[2022/27]
Former [2018/02]HU09.07.2009
BG01.07.2015
CH01.07.2015
CY01.07.2015
CZ01.07.2015
EE01.07.2015
HR01.07.2015
LI01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
MT01.07.2015
PL01.07.2015
RO01.07.2015
SI01.07.2015
SK01.07.2015
SM01.07.2015
LU09.07.2015
NO01.10.2015
IS01.11.2015
Former [2017/38]HU09.07.2009
BG01.07.2015
CH01.07.2015
CY01.07.2015
CZ01.07.2015
EE01.07.2015
HR01.07.2015
LI01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
MT01.07.2015
PL01.07.2015
RO01.07.2015
SI01.07.2015
SK01.07.2015
SM01.07.2015
NO01.10.2015
IS01.11.2015
Former [2017/21]CZ01.07.2015
EE01.07.2015
HR01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
MT01.07.2015
PL01.07.2015
RO01.07.2015
SI01.07.2015
SK01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/36]CZ01.07.2015
EE01.07.2015
HR01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
PL01.07.2015
RO01.07.2015
SI01.07.2015
SK01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/23]CZ01.07.2015
EE01.07.2015
HR01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
PL01.07.2015
RO01.07.2015
SK01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/22]CZ01.07.2015
EE01.07.2015
HR01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
PL01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/18]HR01.07.2015
LT01.07.2015
LV01.07.2015
MC01.07.2015
PL01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/10]HR01.07.2015
LT01.07.2015
LV01.07.2015
PL01.07.2015
NO01.10.2015
IS01.11.2015
Former [2016/09]LT01.07.2015
LV01.07.2015
NO01.10.2015
Former [2016/08]LT01.07.2015
NO01.10.2015
Former [2016/07]LT01.07.2015
Cited inInternational search[XYI]US2003099695  (MUELLER WALTER [DE]) [X] 1,2,5,8,9,11,12,15,16,18,20-22 * example 3; claims 1,4 * [Y] 4,6,13,17,19 [I] 3,7,10;
 [XYI]US2005202073  (JACKSON KRISTIN [US], et al) [X] 1,8,9,11,12,15,16,18,21,22 * paragraphs [0004] - [0008] - [0013] , [0028] - [0030] - [0032] , [0043] , [0067] , [0069] - [0072]; examples 11,14 * [Y] 4,6,13,17,19 [I] 2,3,7,10,20;
 [XY]US2006078602  (KANIOS DAVID [US]) [X] 14,15 * paragraphs [0016] - [0018] - [0103] , [0123]; examples 1-3; claims 1,3 *[Y] 4,6,13,17,19
Examination   - Vivelle-Dot (estradiol transdermal system). Continuous delivery for twice weekly application. Anonymous. Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936. Printed in the USA. Pages 1-4.
OppositionUS2006078602
 US5656286
 US2003099695
 US2006078601
 US2003232073
 EP0887075
    - RIETSCHEL, AKERS, "effects of harvesting techniques on hydration dynamics: gravimetric studies of stratum corneum", J. Soc. Cosmet. Chem., (19780000), vol. 29, pages 777 - 782, XP055264840
    - FELDSTEIN et al., "modelling of percutaneous drug transport in vitro using skin imitating carbosil membrane", J. Contr. Rel., (19980000), vol. 52, pages 25 - 40, XP004113651

DOI:   https://dx.doi.org/10.1016/S0168-3659(97)00208-3
    - GHOSH et al., Transdermal and topical drug delivery systems, (19970000), XP055264843
    - A. JANISCH, Experimental Data
    - Product Information Dow Corning Bio-PSA, (20080807), XP055264844
    - Dow Corning Bio-PSA email
    - Manngold National Starch letter
    - Response Patentee Prosecution
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.